Genetic Leap
Eli Lilly Strikes Multiple Deals for Ultra-Rare Eye Disease Gene Therapy and RNAi Partnerships
Eli Lilly; MeiraGTx; gene therapy; Leber congenital amaurosis-4; AAV-AIPL4; Genetic Leap; RNAi; SanegeneBio; ophthalmology; biotech partnerships
Eli Lilly Expands AI Capabilities with $409M Genetic Leap Partnership
Eli Lilly, AI, Genetic Leap, drug discovery, RNA specialist, pharmaceutical industry
Eli Lilly Partners with Genetic Leap in $409 Million AI-Driven Drug Development Deal
Eli Lilly, Genetic Leap, AI-powered drug deal, oligonucleotide therapy, pharmaceutical partnership